Oliver Luxxe Assets LLC Has $305,000 Stock Position in Mettler-Toledo International, Inc. $MTD

Oliver Luxxe Assets LLC trimmed its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 7.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 260 shares of the medical instruments supplier’s stock after selling 20 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in Mettler-Toledo International were worth $305,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International in the first quarter worth approximately $41,000. Zions Bancorporation National Association UT purchased a new stake in shares of Mettler-Toledo International in the first quarter worth approximately $43,000. Golden State Wealth Management LLC raised its position in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock valued at $48,000 after acquiring an additional 35 shares in the last quarter. Menard Financial Group LLC bought a new position in Mettler-Toledo International during the fourth quarter valued at approximately $67,000. Finally, Blue Trust Inc. raised its position in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock valued at $73,000 after acquiring an additional 52 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently commented on MTD. Bank of America lifted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday. Citigroup lifted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. Evercore ISI dropped their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Barclays began coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target on the stock. Finally, Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International has an average rating of “Moderate Buy” and a consensus price target of $1,325.56.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company’s stock, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares of the company’s stock, valued at $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,257.79 on Tuesday. The stock has a market cap of $25.91 billion, a PE ratio of 31.85, a PEG ratio of 3.79 and a beta of 1.37. The business has a fifty day moving average of $1,266.00 and a two-hundred day moving average of $1,184.96. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business’s revenue was up 3.9% on a year-over-year basis. During the same period last year, the business earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.